SELLAS Life Sciences Group (SLS) Short Interest Ratio & Short Volume → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free SLS Stock Alerts $1.37 0.00 (0.00%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media SELLAS Life Sciences Group Short Interest DataCurrent Short Volume6,990,000 sharesPrevious Short Volume5,670,000 sharesChange Vs. Previous Month+23.28%Dollar Volume Sold Short$8.67 millionShort Interest Ratio / Days to Cover4.6Last Record DateApril 30, 2024Outstanding Shares57,760,000 sharesPercentage of Shares Shorted12.10%Today's Trading Volume859,090 sharesAverage Trading Volume1,495,729 sharesToday's Volume Vs. Average57% Short Selling SELLAS Life Sciences Group ? Sign up to receive the latest short interest report for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSLS Short Interest Over TimeSLS Days to Cover Over TimeSLS Percentage of Float Shorted Over Time Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. SELLAS Life Sciences Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20246,990,000 shares $8.67 million +23.3%N/A4.6 $1.24 4/15/20245,670,000 shares $7.54 million +7.6%N/A4 $1.33 3/31/20245,270,000 shares $5.32 million +1.7%N/A3.6 $1.01 3/15/20245,180,000 shares $5.70 million +14.9%N/A3.7 $1.10 2/29/20244,510,000 shares $4.56 million +15.9%N/A4.2 $1.01 2/15/20243,890,000 shares $2.74 million +24.7%N/A3.7 $0.70 Get the Latest News and Ratings for SLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,120,000 shares $2.00 million -19.6%N/A3.1 $0.64 1/15/20243,880,000 shares $2.07 million -18.0%N/A4.3 $0.53 12/31/20234,730,000 shares $5.01 million +1.5%N/A4.9 $1.06 12/15/20234,660,000 shares $5.36 million +1.1%N/A6.3 $1.15 11/30/20234,610,000 shares $4.79 million +0.7%N/A7.3 $1.04 11/15/20234,580,000 shares $4.44 million +50.2%N/A8.7 $0.97 10/31/20233,050,000 shares $2.96 million +49.5%N/A6.6 $0.97 10/15/20232,040,000 shares $2.65 million +87.2%N/A6.5 $1.30 9/30/20231,090,000 shares $1.79 million +6.9%N/A7.7 $1.64 9/15/20231,020,000 shares $1.64 million -9.7%N/A8.1 $1.61 8/31/20231,130,000 shares $1.66 million No ChangeN/A8.9 $1.47 8/15/20231,130,000 shares $1.68 million -4.2%N/A8.7 $1.49 7/31/20231,180,000 shares $1.94 million +2.6%N/A8.2 $1.64 7/15/20231,150,000 shares $1.97 million -0.9%N/A7.4 $1.71 6/30/20231,160,000 shares $1.82 million +3.6%N/A6.8 $1.57 6/15/20231,120,000 shares $1.86 million -5.9%N/A5.4 $1.66 5/31/20231,190,000 shares $2.04 million -4.8%N/A4.8 $1.72 5/15/20231,250,000 shares $2.05 million +4.2%N/A2.7 $1.64 4/30/20231,200,000 shares $1.69 million +1.7%N/A2.6 $1.41 4/15/20231,180,000 shares $1.89 million +7.3%N/A2.6 $1.60 3/31/20231,100,000 shares $1.57 million -9.8%N/A2.4 $1.43 3/15/20231,220,000 shares $1.68 million -5.4%N/A3 $1.38 2/28/20231,290,000 shares $2.18 million +7.5%N/A3.5 $1.69 2/15/20231,200,000 shares $3.79 million +2.6%N/A4.1 $3.16 1/31/20231,170,000 shares $3.88 million -2.5%N/A4.5 $3.32 1/15/20231,200,000 shares $3.41 million -3.2%N/A3.6 $2.84 12/30/20221,240,000 shares $2.93 million +0.8%N/A3.3 $2.36 12/15/20221,230,000 shares $2.85 million +1.7%N/A3.4 $2.32 11/30/20221,210,000 shares $2.89 million +5.2%N/A3.3 $2.39 11/15/20221,150,000 shares $2.58 million +15.4%N/A3.3 $2.24 10/31/2022996,800 shares $4.67 million +21.3%N/A3.8 $4.68 10/15/2022822,000 shares $1.57 million -0.9%N/A4.5 $1.91 9/30/2022829,600 shares $1.68 million -0.7%N/A8.3 $2.02 9/15/2022835,100 shares $2.51 million +0.1%N/A7.8 $3.00My system predicted the BA collapse – now it’s issuing an AI warning (Ad)Even after several plane crashes and equipment malfunctions... a congressional hearing... and the worst PR firestorm in recent memory... The FTC's commission chair Lina Khan still deems Boeing (BA), "too big to fail" Click to see why a similar situation is currently brewing in the AI market... SLS Short Interest - Frequently Asked Questions What is SELLAS Life Sciences Group's current short interest? Short interest is the volume of SELLAS Life Sciences Group shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 6,990,000 shares of SLS short. Learn More on SELLAS Life Sciences Group's current short interest. What is a good short interest ratio for SELLAS Life Sciences Group? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLS shares currently have a short interest ratio of 5.0. Learn More on SELLAS Life Sciences Group's short interest ratio. Is SELLAS Life Sciences Group's short interest increasing or decreasing? SELLAS Life Sciences Group saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 6,990,000 shares, an increase of 23.3% from the previous total of 5,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does SELLAS Life Sciences Group's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to SELLAS Life Sciences Group: vTv Therapeutics Inc. (3.18%), Anebulo Pharmaceuticals, Inc. (0.19%), Reviva Pharmaceuticals Holdings, Inc. (4.48%), Leap Therapeutics, Inc. (5.57%), InflaRx (0.22%), Affimed (1.54%), Rallybio Co. (9.67%), YS Biopharma Co., Ltd. (0.32%), Tempest Therapeutics, Inc. (9.42%), LifeVantage Co. (0.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short SELLAS Life Sciences Group stock? Short selling SLS is an investing strategy that aims to generate trading profit from SELLAS Life Sciences Group as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against SELLAS Life Sciences Group? A short squeeze for SELLAS Life Sciences Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLS, which in turn drives the price of the stock up even further. How often is SELLAS Life Sciences Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: VTVT Short Interest Data ANEB Short Interest Data RVPH Short Interest Data LPTX Short Interest Data IFRX Short Interest Data AFMD Short Interest Data RLYB Short Interest Data YS Short Interest Data TPST Short Interest Data LFVN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLS) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressElon to Transform U.S. Economy? Porter & CompanyThe only AI company you should be looking atBehind the Markets